Showing results (61-70 of 451) with videos related to

Sort By:
Pageof 46
Current Opinion in Lipidology|October 15, 2014
Pharmacogenomics of statin therapy: any new insights in efficacy or safety?Jemma C Hopewell, Christina Reith, Jane Armitage
Heart (British Cardiac Society)|November 16, 2007
Metabolic syndrome, dysglycaemia and vascular disease: making sense of the evidenceDavid Preiss, Naveed Sattar
International Journal of Clinical Practice|February 8, 2002
The MRC/BHF Heart Protection Study: preliminary resultsRory Collins, Richard Peto, Jane Armitage
Clinical Endocrinology|December 11, 2008
Lipids, lipid modifying agents and cardiovascular risk: a review of the evidenceDavid Preiss, Naveed Sattar
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2016
Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)Natalie Staplin, Richard Haynes, William G Herrington, et al.
Plos One|November 1, 2011
Estimated glomerular filtration rate and the risk of major vascular events and all-cause mortality: a meta-analysisMarion Mafham, Jonathan Emberson, Martin J Landray, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 16, 2017
Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal ProtectionMarion M Mafham, Natalie Staplin, Jonathan Emberson, et al.
Seminars in Dialysis|July 22, 2014
Evidence for the prevention and treatment of stroke in dialysis patientsWilliam Herrington, Richard Haynes, Natalie Staplin, et al.
Pageof 46